Sunday, August 16, 2015 10:46:16 AM
EPIC-E is open label, unblinded study: https://clinicaltrials.gov/ct2/show/NCT02449616?term=mast+therapeutics&rank=2
The mom of that child from Sickle Cell Unite that shared the "No pain" after being on MST-118 after 24hrs must of been enrolled in EPIC-E, or she wouldn't of known what he was dosed on. EPIC-E started in May and is enrolling 388, we may start seeing a lot more of these patient experiences being shared.
"at little pr goes a long way."
Brian is addressing.
"we are being severely undervalued by the marketplace. Consequently, on September 3rd, we will be presenting at Fourth Annual Sickle Cell Drug Development Conference and on October 7th, we plan to host our first-ever Mast R&D event. Botsh of these events will be held in New York City and every investor and analyst in our database will be invited to attend. We also will webcast our R&D event on October for those investors who cannot attend in person."
BTW, If anyone thinks Brian is not a hard worker, I'd think again, this man routinely answers my emails at 5:30am. From the tone of the EPS CC, you can surmise how focused he is on presenting an amazing and thorough NDA package to the FDA. The typical NDA has thousands and thousands of pages and could fill up the back of a truck. All that you heard on the CC is being completed due to MANY hours of hard work being put in by Brian and his team.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM